Methylestrenolone

Methylestrenolone

Methylestrenolone is a synthetic, anabolic steroid that was developed in the 1960s. It is a derivative of nandrolone, which is itself a derivative of testosterone. Methylestrenolone is also known by its chemical name, 17α-methyl-19-nor-4,9,11-estratetraen-3-one.

History

Methylestrenolone was first synthesized in the 1960s. It was developed as a potential therapeutic agent for the treatment of anemia and muscle wasting conditions. However, its use in humans was discontinued due to its high potential for side effects and the development of more effective and safer alternatives.

Pharmacology

Methylestrenolone is a progestin and a 17α-alkylated anabolic steroid. It has a high androgenic activity and a moderate anabolic activity. The drug is metabolized in the liver and excreted in the urine.

Side Effects

The side effects of methylestrenolone are similar to those of other anabolic steroids. They include liver damage, cardiovascular disease, gynecomastia, acne, hair loss, and mood changes. The drug can also cause virilization in women and testicular atrophy in men.

Legal Status

Methylestrenolone is classified as a controlled substance in many countries, including the United States, Canada, and the United Kingdom. It is also on the World Anti-Doping Agency's list of prohibited substances.

See Also

• Anabolic steroid
• Nandrolone
• Testosterone

‎